Andreas Leodolter

Andreas Leodolter

Medical Department, Ev.-Jung-Stilling Hospital, Academic Hospital Of The University Of Bonn, Siegen, Germany;, Cattedra Di Gastroenterologia, Dipartimento Di Scienze Mediche, ...

Direct Impact

Concepts for which Andreas Leodolter has direct influence:

rescue therapy
pylori infection
phase iii
moxifloxacin amoxicillin
remains challenge

Prominent publications by Andreas Leodolter

KOL-Index: 6 On-demand proton pump inhibitor (PPI) therapy is an attractive option for long-term management of gastroesophageal reflux disease (GERD). Controlled trials in non-erosive reflux disease (NERD) patients have shown sufficient symptom control in most patients with a high rate of willingness to continue treatment and substantial saving on PPI expenditure. However, due to the slow onset of action ...
Known for
Heartburn | Barretts Esophagus | Long-Term Management | Cost-Saving
KOL-Index: 2 Successful H. pylori eradication therapy remains a challenge in medical practice. Despite promising data for first-line, second-line and rescue treatment options based on clinical trials as well as guidelines and expert recommendations, success rates can often not be reproduced in general practice. Rescue options for patients with failed initial or second-line therapy are definitely needed. ...
Known for
Excitatory Effects | Optimal Duration | Broad Antibacterial | Potential Candidates

Medical Department, Ev.-Jung-Stilling Hospital, Academic Hospital of the University of Bonn, Siegen, Germany;, Cattedra di Gastroenterologia, Dipartimento di Scienze Mediche, University of Milan, and Fondazione IRCCS Ospedale Maggiore, Mangiagalli, R

© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172